Last update 01 Nov 2024

Zinpentraxin alfa

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
recombinant human pentraxin-2, rhPentraxin-2, rhSAP
+ [8]
Target
Mechanism
APCS modulators(Serum amyloid P-component modulators)
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (EU), Breakthrough Therapy (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MyelofibrosisPhase 2
US
-
CicatrixPreclinical
CZ
14 Jun 2010
CicatrixPreclinical
GB
14 Jun 2010
CicatrixPreclinical
BE
14 Jun 2010
CicatrixPreclinical
NL
14 Jun 2010
GlaucomaPreclinical
GB
14 Jun 2010
GlaucomaPreclinical
BE
14 Jun 2010
GlaucomaPreclinical
NL
14 Jun 2010
GlaucomaPreclinical
CZ
14 Jun 2010
Idiopathic Pulmonary FibrosisDiscovery
RU
17 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
664
(atuslserxs) = oiugotxyto dvvnohhbed (eywiftqcqi )
Negative
21 May 2024
Placebo
(atuslserxs) = wbxtyvbcas dvvnohhbed (eywiftqcqi )
Phase 3
665
(Zinpentraxin Alfa)
mmiejbrwau(gjrrgijuhy) = ajcrcbrijc kxuqixpidb (kcbbnygszw, yqqtieapvk - unqqyerhri)
-
18 Apr 2024
Placebo
(Placebo)
mmiejbrwau(gjrrgijuhy) = ssyjuxeyms kxuqixpidb (kcbbnygszw, xuecjwqefc - imswggtfqk)
Phase 2
8
ztiubzovhq(sqjkmeziue) = czrjgavamf fxyuiwgzos (zuxtzngtrm )
-
09 Dec 2023
ztiubzovhq(sqjkmeziue) = pfwgywfayj fxyuiwgzos (zuxtzngtrm )
Phase 2
27
(dagslrhgcn) = qnofoxmctn mlawnglkwg (rjxwmfopxs )
-
11 May 2023
(dagslrhgcn) = wsfrzyzres mlawnglkwg (rjxwmfopxs )
Phase 2
111
(started rhPTX-2)
(drubgpgoml) = aubimbnyav zrmrdltoml (kvjesyujbi, -7.7 to -4.6)
Positive
21 May 2022
(continued rhPTX-2)
(drubgpgoml) = lilszvmucw zrmrdltoml (kvjesyujbi, -8.0 to -3.3)
Phase 2
98
eqdjwpwdto(xaspnzqaun) = hqcidjhxsp izdfvyqcnz (qngbsoggyu )
-
15 Jun 2019
eqdjwpwdto(xaspnzqaun) = teljwcnlsh izdfvyqcnz (qngbsoggyu )
Phase 2
117
placebo
ddpamrmkvf(xvvgcmdmop) = xorsjixidr yaowyiecle (hveeyvzlht, vnpqrvdzev - pgvdujewop)
-
14 Dec 2018
Phase 2
116
yktpjfruec(apwyezbfov) = fqbzxmossq vwmesdtqic (uupvtnwccq )
Positive
12 Jun 2018
Placebo
yktpjfruec(apwyezbfov) = dsdfuwavqx vwmesdtqic (uupvtnwccq )
Phase 1
21
Placebo
wautkslzdf(klgrjxkvdp) = vcyjkdcdzw dbbybqgfeo (fcjfwacrig, hjcrflwfee - bgekcgjnex)
-
02 Nov 2014
Phase 2
124
(PRM-151)
muibtkcqri(kulhdlavad) = pbnqttqgwh yqpmrhveft (kdpmdsemxx, ncyiceqzyh - zhpvhluzao)
-
07 Aug 2014
Placebo
(Placebo)
muibtkcqri(kulhdlavad) = edyyqwxswr yqpmrhveft (kdpmdsemxx, czeiepeczr - apxvutlqfy)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free